Novo Nordisk cuts 650 roles around the world in R&D restructure
October 1, 2018Manufacturing and Production, Sales and Marketing China, Denmark, Novo Nordisk, UK, US, pharma
Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …
Antibody therapy supresses HIV for months after treatment, study shows
October 1, 2018Sales and Marketing HIV, immunology, immunotherapy, nature, research
Researchers from the New York City based Rockefeller University have developed a novel immunotherapy, which is capable of suppressing HIV …
Roche acquires immuno-oncology biotech Tusk in €655m deal
October 1, 2018Sales and Marketing Droia, Roche, Tusk, immuno-oncology, immunology, oncology
Swiss multinational Roche has acquired the privately held immuno-oncology company Tusk Therapeutics in a deal that could be worth up …
Ipsen appoints two leading R&D experts in bid to strengthen oncology arm
September 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, R&D, development, ipsen, oncology, research
French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …
Top Ten most popular articles on Pharmafile.com this week
September 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma
Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …
Novartis strike $40m deal with Chinese firm Cellular Biomedicine
September 28, 2018Medical Communications CAR T, CAR-T, China, Kymriah, Novartis, cellular biomedicine, prc
Swiss multinational Novartis have paired up with Chinese drugmaker Cellular Biomedicine (CBMG) in order to manufacture CAR-T therapy Kymriah in …
Gilead to release generic versions of hep C meds over a decade before patent expiry
September 28, 2018Medical Communications, Sales and Marketing Epclusa, Gilead, generics, harvoni, hepatitis C, pharma
Gilead has announced its intention to undercut itself by releasing generic versions of its blockbuster drugs for the treatment of …
UK government accused of using Brexit to avoid antimicrobial resistance ruling
September 28, 2018Medical Communications AMR, Antibiotics, UK, WHO, antimicrobial resistance, farming, politics
The British government has been accused of using Brexit to avoid implementing new EU legislation preventing powerful antibiotics from be …
Percentage of life sciences professionals using blockchain has tripled since 2017
September 27, 2018Medical Communications blockchain, pharma, pistoia alliance, technology
A survey conducted by The Pistoia Alliance, a not-for-profit coalition of life science companies, vendors, publishers and academic groups, has …
Novartis joins forces with GARDP for better, accessible infectious disease treatments in the developing world
September 27, 2018Research and Development, Sales and Marketing GARDP, Novartis, infectious disease, pharma
Novartis has partnered up with the Global Antibiotic Research & Development Partnership (GARDP) to push for faster development and wider …
Researchers eliminate mosquito population through CRISPR gene editing technology
September 27, 2018Research and Development crispr, gene editing, imperial college london, malaria, mosquitoes
Researchers at Imperial College London have been able to wipe out a population of mosquitoes through ‘gene drive’ technology. The …
Life Sciences Scotland appoints two MSPs to their Industry Leadership Group
September 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Scotland, Scotland, economic development, pharma
Life Sciences Scotland, an organisation focused towards developing the life sciences industry in the northernmost constituent country of the United …
Kenneth Frazier to continue as CEO as MSD rescinds mandatory retirement policy
September 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kenneth Frazier, MSD, pharma
MSD has pitched a curveball with the news that the company has rescinded its policy mandating that Chief Executive Officers …
EMA says pharma industry now more prepared for Brexit
September 27, 2018Manufacturing and Production, Medical Communications EMA, EU, brexit, products, qppv
In July of this year the European Medicines Agency (EMA) identified significant gaps in the pharmaceutical industry’s preparedness for Brexit. …
The October 2018 issue of Pharmafocus is available to read online now!
September 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma
The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …
Alexion’s Soliris almost entirely eliminates relapses in rare neuromyelitis optica spectrum disorder
September 26, 2018Research and Development Alexion, neuromyelitis optica spectrum disorder, pharma, rare disease, soliris
Alexion has revealed new Phase 3 findings for Soliris (eculizumab), showing the drug met its primary endpoint in the treatment …
Takeda’s lung cancer treatment Alunbrig proves successful in Phase III trial
September 26, 2018Research and Development Alunbrig, R&D, Takeda, phase III, research
Japanese pharma firm Takeda have announced that lung cancer treatment Alunbrig has proven successful in reducing the risk of disease …
Roche’s Tecentriq+chemo combo shows first-line benefit in small cell lung cancer
September 26, 2018Research and Development Cancer, Combo, Roche, chemotherapy, lung cancer, pharma, tecentriq
Roche has unveiled new Phase 3 data for its cancer immunotherapy Tecentriq (atezolizumab) in combination with carboplatin and etoposide chemotherapy …
Life expectancy falls in Scotland for first time in 35 years
September 26, 2018Research and Development Scotland, UK, health, life expectancy, uk politics
Life expectancy has fallen for the first time in 35 years in Scotland, as data released by the National Records …
AstraZeneca CEO suggests he’s the ‘lowest paid CEO in the whole industry’ as he raises concerns surrounding Brexit
September 25, 2018Business Services, Research and Development
Pascal Soriot, the Chief Executive Officer of the Anglo-Swedish multinational AstraZeneca, has raised concerns that he is being underpaid, despite …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
